Dr. Mehmet Oz holds millions from companies that he'd wield power over if confirmed, report shows
Dr. Mehmet Oz holds millions of dollars worth of shares in health insurance, fertility, pharmaceutical and vitamin companies.
Republicans consider cuts and work requirements for Medicaid, jeopardizing care for millions
Republicans are weighing billions of dollars in cuts to Medicaid, jeopardizing health care coverage for some of the 80 ...
Key Musk DOGE adviser meets with leaders of Medicare agency
A key member of Elon Musk's Department of Government Efficiency has met with leadership at the Centers for Medicare & ...
White House Signals Medicare Is Not Protected, Despite Trump Promise
This comes after President said in interview with Fox News' Sean Hannity that Medicare and Medicaid would be "untouched." ...
Benefits Pro3d
Health care spending varies dramatically across U.S. counties
U.S. health expenditures surged by 7.5%, reaching $4.9 trillion, or an average of $14,570 per person, according to the ...
Commonwealth Fund1d
How Much Do Medicare Advantage Enrollees Value and Use Their Supplemental Benefits?
Although most Medicare Advantage enrollees are in plans with supplemental benefits, survey findings show many of these ...
What could DOGE mean for Medicare and Medicaid?
It recently accessed systems at the Centers for Medicare and Medicaid Services. Musk and his team now are looking at key ...
Medicare, FDA staff among those fired in Trump administration purge - report
Employees at the Centers for Medicare and Medicaid Services (CMS), Food and Drug Administration (FDA), and Centers for ...
The 19th News on MSN1d
Trump disbands health equity panel examining Medicare and Medicaid
The committee was designed to reduce barriers to care for people of color, LGBTQ+ people and rural Americans. A new executive ...
Georgia Republican faces town hall backlash over DOGE's 'chainsaw approach' to government cuts
Rep. Rich McCormick, who represents a safe GOP district, came under harsh criticism that focused on the Trump ...
Regeneron Pharmaceuticals (REGN) Faces Mounting Pressure on Sales, Legal Fronts- Hagens Berman
Regeneron is also embroiled in a securities fraud class action lawsuit stemming from a significant stock price drop on October 31, 2024. Shares plunged $84.59 that day, wiping out approximately $9 ...